Breaking News Bar

Business News and Information

Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs

As Daniel O'Day takes the helm of Gilead, replacing longtime Chairman Bill Martin and CEO Bill Milligan, Roche will moves Genentech CEO into O'Day's old position and look for Genentech's fifth CEO in less than 10 years.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear